General form of registration statement for all companies including face-amount certificate companies

Net Loss Per Share of Common Stock (Tables)

v3.20.2
Net Loss Per Share of Common Stock (Tables)
6 Months Ended 12 Months Ended
Jun. 30, 2020
Dec. 31, 2019
Earnings Per Share [Abstract]    
Schedule of Net Loss Per Share Basic and Diluted

The computation of net loss per share for the six months ended June 30, 2020 and 2019 was as follows:

 

   

Six months ended

June 30,

 
    2020     2019  
Basic and diluted net loss per share:                
Net loss   $ (1,607,750 )   $ (1,719,910 )
Weighted average number of common stock-basic and diluted     5,515,447       5,524,895  
                 
Basic and diluted net loss per share   $ (0.29 )   $ (0.31 )

The computation of net loss per share for the year ended December 31, 2019 and 2018 was as follows:

 

    2019     2018  
Basic and diluted net loss per share:                
Net loss   $ (3,357,876 )   $ (3,765,047 )
Deemed dividend related to the triggering of the full ratchet anti-dilution provision at fair value     (506,993 )     -  
Net loss available to common stockholders     (3,864,869 )     (3,765,047 )
                 
Weighted-average number of common stock-basic and diluted     5,525,635       5,332,141  
                 
Basic and diluted net loss per share   $ (0.70 )   $ (0.71 )
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following potentially dilutive securities were excluded from the computation of diluted net income per share as their effect would have been anti-dilutive for the periods presented.

 

    2020     2019  
Stock options and purchase warrants     646,938       700,976  
Senior convertible notes and LOC, plus related accrued interest     93,961       18,107  
      740,899       719,083  

The outstanding options and warrants to purchase common stock and the shares issuable under the 2017 and 2019 Senior Notes were excluded from the computation of diluted net income per share as their effect would have been anti-dilutive for the periods are presented below:

 

    2019     2018  
Stock options and purchase warrants     654,569       571,055  
Senior convertible notes     60,883       17,531